Работы, на которые ссылается эта работа

Работ: 44

Работа: Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4
СтатьяGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians2021Цитирований: 60
ABI
Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature
Yingzhi Chen, Meng Zhang, Hongyue Jin +6
Статья2016Цитирований: 7
ABI
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp +2
Обзорная статья2016Цитирований: 5
ABI
Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance
Yingzhi Chen, Meng Zhang, Hongyue Jin +4
Статья2017Цитирований: 5
ABI
Dual-targeting biomimetic delivery for anti-glioma activityviaremodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
Pengfei Zhao, Yonghui Wang, Xuejia Kang +7
Статья2018Цитирований: 4
ABI
Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFRT790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery
Weimin Yin, Xiaolu Yu, Xuejia Kang +7
Статья2018Цитирований: 4
ABI
Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis
Yisi Tang, Jianming Liang, Aihua Wu +7
Статья2017Цитирований: 4
ABI
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery
Yingzhi Chen, Meng Zhang, Hongyue Jin +5
Статья2017Цитирований: 4
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Обзорная статья2021Цитирований: 4
ABI
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek +4
Обзорная статья2019Цитирований: 3
ABI
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Обзорная статья2020Цитирований: 3
ABI
Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
Aihua Wu, Yingzhi Chen, Hairui Wang +8
Статья2021Цитирований: 3
ABI
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer +23
Статья2021Цитирований: 3
ABI
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren +51
Обзорная статья2020Цитирований: 2
ABI
Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
Zhidi He, Meng Zhang, Yonghui Wang +6
Статья2020Цитирований: 2
ABI
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco, Purushottam Lamichhane, Lavakumar Karyampudi +1
Обзорная статья2015Цитирований: 2
ABI
Dendritic Cells and Cancer Immunity
Alycia Gardner, Brian Ruffell
Обзорная статья2016Цитирований: 2
ABI
Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment
Yisi Tang, Wufa Fan, Guihua Chen +8
Статья2021Цитирований: 2
ABI
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation
Weimin Yin, Yuge Zhao, Xuejia Kang +5
Статья2020Цитирований: 2
ABI
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
Zening Zheng, Jiaxin Zhang, Jizong Jiang +7
Статья2020Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI

Работы, на которые ссылается эта работа

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

Immunogenic cell death in cancer and infectious disease

Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance

Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis

Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery

Diagnosis and Treatment of Metastatic Colorectal Cancer

Immunotherapy in colorectal cancer: rationale, challenges and potential

Detection of immunogenic cell death and its relevance for cancer therapy

Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy

Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

Dendritic Cells and Cancer Immunity

Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment

BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Без названия

Без названия

Без названия

Без названия

Без названия